Tectonic Therapeutic, Inc. TECX

23.67 (0.45) (1.87%) as of 25 Sep
Market cap
$471.5M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Current Ratio
26.63 12.65 0.76 7.62 10.27 16.09 13.96 12.26 2.40 6.03
Net Debt/EBITDA
3.08 2.50 0.65 0.75 1.49 2.18 2.50 2.76 0.33 1.16
Debt/Assets
0.02% 0.25% 2.22% 14.70% 7.33% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 (0.01) 0.20 0.09 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income
0.81 1.02 0.95 0.92 0.82 0.83 0.93 0.77 0.87 0.67
Capex/Depreciation
(0.10) (0.09) (0.19) (0.19) (1.76) (0.98) (1.86) (4.39) (5.55) —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(37.82%) (206.56%) 924.30% (86.50%) (56.22%) (54.37%) (47.35%) (98.14%) 135.19% 35.86%
ROA
(35.83%) (60.30%) (59.75%) (68.81%) (50.15%) (50.75%) (43.69%) (69.19%) (301.61%) (80.00%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(29.79%) (42.20%) 622.25% (118.00%) (64.78%) (47.19%) (39.36%) (39.82%) (464.61%) (110.79%)
Average Days of Receivables
— — — 0.00 0.00 0.00 0.00 0.00 — —
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(3.29) (6.98) (32.28) (2.23) (2.34) (2.76) (2.52) (2.94) (7.50) (1.63)
Cash per Share
13.88 16.64 22.67 2.12 4.42 7.17 6.82 9.40 2.67 2.63
Shareholders Equity per Share
13.72 16.58 (66.69) 1.72 3.95 7.02 6.78 9.09 (10.35) (2.25)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
13.72 16.58 (66.69) 1.72 3.95 7.02 6.78 9.09 (10.35) (2.25)
Free Cash Flow
(60.22) (59.24) (40.96) (97.47) (100.49) (99.98) (69.25) (39.48) (16.76) (3.31)
Working Capital
247.69 135.25 (10.00) 86.84 179.76 250.63 181.68 119.41 3.68 4.49
Capital Expenditures
(0.14) (0.16) (0.28) (0.27) (2.46) (1.18) (1.58) (1.83) (0.38) —
Net Current Asset Value
247.65 134.73 (93.15) 71.38 164.78 250.35 181.20 118.73 (23.85) (4.60)
Other line items
Quick Ratio
26.32 12.17 0.70 7.08 9.78 15.63 13.34 11.91 2.27 6.01
Depreciation/Fixed assets
1.16 0.76 0.47 0.50 0.34 0.39 0.23 0.16 0.20 —
Cash ROIC
(12.11%) (21.68%) 79.65% (54.55%) (27.31%) (19.82%) (19.13%) (16.21%) 97.43% (425.96%)
Accounts Receivable Turnover
— — — 0.00 0.00 0.00 0.00 0.00 — —
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
— — — 0.00 0.00 0.00 0.00 0.00 0.00 —
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — — 0.00 0.00 0.00 0.00 0.00 0.00 —
Revenue per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF per Share
(3.28) (6.96) (32.06) (2.22) (2.29) (2.73) (2.47) (2.80) (7.33) (1.63)
Capex per Share
(0.01) (0.02) (0.22) (0.01) (0.06) (0.03) (0.06) (0.14) (0.17) 0.00
Average Receivables
— — — 1.48 2.63 2.35 1.84 1.84 — —
Average Payables
1.03 0.69 0.40 1.94 3.08 3.32 3.37 1.66 0.43 0.43
Average Assets
206.97 96.15 71.67 153.89 237.54 235.87 167.00 70.25 6.21 6.21
Average Common Equity
196.05 28.07 (4.63) 122.42 211.91 220.18 154.10 49.52 (13.86) (13.86)
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Net Profit Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates